These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26187015)

  • 21. 177Lu-AMBA biodistribution, radiotherapeutic efficacy, imaging, and autoradiography in prostate cancer models with low GRP-R expression.
    Maddalena ME; Fox J; Chen J; Feng W; Cagnolini A; Linder KE; Tweedle MF; Nunn AD; Lantry LE
    J Nucl Med; 2009 Dec; 50(12):2017-24. PubMed ID: 19910427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melatonin Analogue Antiproliferative and Cytotoxic Effects on Human Prostate Cancer Cells.
    Calastretti A; Gatti G; Lucini V; Dugnani S; Canti G; Scaglione F; Bevilacqua A
    Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29783631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor agents 290. Design, synthesis, and biological evaluation of new LNCaP and PC-3 cytotoxic curcumin analogs conjugated with anti-androgens.
    Shi Q; Wada K; Ohkoshi E; Lin L; Huang R; Morris-Natschke SL; Goto M; Lee KH
    Bioorg Med Chem; 2012 Jul; 20(13):4020-31. PubMed ID: 22672984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pin1 Inhibitor Juglone Exerts Anti-Oncogenic Effects on LNCaP and DU145 Cells despite the Patterns of Gene Regulation by Pin1 Differing between These Cell Lines.
    Kanaoka R; Kushiyama A; Seno Y; Nakatsu Y; Matsunaga Y; Fukushima T; Tsuchiya Y; Sakoda H; Fujishiro M; Yamamotoya T; Kamata H; Matsubara A; Asano T
    PLoS One; 2015; 10(6):e0127467. PubMed ID: 26039047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and evaluation of novel oxadiazole derivatives as potential prostate cancer agents.
    Mochona B; Qi X; Euynni S; Sikazwi D; Mateeva N; Soliman KF
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2847-2851. PubMed ID: 27156770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A novel epoxypropoxy flavonoid derivative and topoisomerase II inhibitor, MHY336, induces apoptosis in prostate cancer cells.
    Patra N; De U; Kang JA; Kim JM; Ahn MY; Lee J; Jung JH; Chung HY; Moon HR; Kim HS
    Eur J Pharmacol; 2011 May; 658(2-3):98-107. PubMed ID: 21376033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel histone deacetylase (HDAC) inhibitor MHY219 induces apoptosis via up-regulation of androgen receptor expression in human prostate cancer cells.
    Patra N; De U; Kim TH; Lee YJ; Ahn MY; Kim ND; Yoon JH; Choi WS; Moon HR; Lee BM; Kim HS
    Biomed Pharmacother; 2013 Jun; 67(5):407-15. PubMed ID: 23583193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis, biological assessment and molecular modeling studies of novel imidazothiazole-thiazolidinone hybrids as potential anticancer and anti-inflammatory agents.
    Kamboj P; Anjali ; Imtiyaz K; Rizvi MA; Nath V; Kumar V; Husain A; Amir M
    Sci Rep; 2024 Apr; 14(1):8457. PubMed ID: 38605072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, modeling studies and biological evaluation of pyrazole derivatives linked to oxime and nitrate moieties as nitric oxide donor selective COX-2 and aromatase inhibitors with dual anti-inflammatory and anti-neoplastic activities.
    A A Fadaly W; A M M Elshaier Y; T M Nemr M; R A Abdellatif K
    Bioorg Chem; 2023 May; 134():106428. PubMed ID: 36893546
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Innovative C
    Paquin A; Oufqir Y; Sevrioukova IF; Reyes-Moreno C; Bérubé G
    Eur J Med Chem; 2021 Aug; 220():113496. PubMed ID: 33933755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of androgen receptor transactivity and mTOR-S6 kinase pathway by Rheb in prostate cancer cell proliferation.
    Kobayashi T; Shimizu Y; Terada N; Yamasaki T; Nakamura E; Toda Y; Nishiyama H; Kamoto T; Ogawa O; Inoue T
    Prostate; 2010 Jun; 70(8):866-74. PubMed ID: 20127734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design, synthesis and biological evaluation of rhein-piperazine-dithiocarbamate hybrids as potential anticancer agents.
    Wei MX; Zhou YX; Lin M; Zhang J; Sun X
    Eur J Med Chem; 2022 Nov; 241():114651. PubMed ID: 35963130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sodium bicarbonate transporter NBCe1 regulates proliferation and viability of human prostate cancer cells LNCaP and PC3.
    Li JM; Lee S; Zafar R; Shin E; Choi I
    Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34013380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines.
    Brown I; Cascio MG; Wahle KW; Smoum R; Mechoulam R; Ross RA; Pertwee RG; Heys SD
    Carcinogenesis; 2010 Sep; 31(9):1584-91. PubMed ID: 20660502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors.
    Behbahani FS; Tabeshpour J; Mirzaei S; Golmakaniyoon S; Tayarani-Najaran Z; Ghasemi A; Ghodsi R
    Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800307. PubMed ID: 31012156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The aryl hydrocarbon receptor is constitutively active in advanced prostate cancer cells.
    Richmond O; Ghotbaddini M; Allen C; Walker A; Zahir S; Powell JB
    PLoS One; 2014; 9(4):e95058. PubMed ID: 24755659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytotoxicity of 2,3-dichloro-5,8-dimethoxy-1,4-naphthoquinone in androgen-dependent and -independent prostate cancer cell lines.
    Copeland RL; Das JR; Bakare O; Enwerem NM; Berhe S; Hillaire K; White D; Beyene D; Kassim OO; Kanaan YM
    Anticancer Res; 2007; 27(3B):1537-46. PubMed ID: 17595773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis and biological evaluation of novel thiohydantoin derivatives as potent androgen receptor antagonists for the treatment of prostate cancer.
    Wang A; Wang Y; Meng X; Yang Y
    Bioorg Med Chem; 2021 Feb; 31():115953. PubMed ID: 33388655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. mTOR is a fine tuning molecule in CDK inhibitors-induced distinct cell death mechanisms via PI3K/AKT/mTOR signaling axis in prostate cancer cells.
    Berrak O; Arisan ED; Obakan-Yerlikaya P; Coker-Gürkan A; Palavan-Unsal N
    Apoptosis; 2016 Oct; 21(10):1158-78. PubMed ID: 27484210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and anticancer evaluation of 6-azacyclonol-2,4,6-trimethylpyridin-3-ol derivatives: M3 muscarinic acetylcholine receptor-mediated anticancer activity of a cyclohexyl derivative in androgen-refractory prostate cancer.
    Karmacharya U; Chaudhary P; Lim D; Dahal S; Awasthi BP; Park HD; Kim JA; Jeong BS
    Bioorg Chem; 2021 May; 110():104805. PubMed ID: 33725508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.